Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

First Human Clinical Trial Proves TruZen® CBD Formula with Patented VESIsorb® Technology Achieves 360% greater Bioavailability of β-caryophyllene (BCP)


TruZen®  CBD

TruZen® CBD

We are very excited by the results of this first ever human-based clinical trial, validating our proprietary TruZen® formula with VESIsorb®’s superior potency and absorbency of β-caryophyllene (BCP).

Nutraceuticals Innovator TruZen® Health has announced the results of a first ever human-based clinical trial, proving its proprietary TruZen® CBD formula with patented VESIsorb® Technology achieves 360% greater bioavailability of β-caryophyllene (BCP).

BCP is a natural bicyclic sesquiterpene and a common constituent of the essential oils of numerous food plants such as hemp (Cannabis sativa L) and is thought to interact with the endocannabinoid system by binding selectively to cannabinoid receptors type 2 (CB2). Decades of preclinical research have investigated the potential therapeutic benefits of BCP, such as analgesic, anti-inflammatory, and anti-depressive.

The clinical trial, a randomized, double-blind, cross-over design, single oral dose study1 [100 mg β-caryophyllene (BCP)] in 24 healthy subjects (12 men/12 women) was performed under fasted conditions and evaluated the relative bioavailability of BCP formulated with VESIsorb® to that of the same BCP neat oil. In addition to the superior PK results of the BCP VESIsorb® formulation, there are significant findings that highlight the scientific and medical contributions from this new study.


  • This is the first published study to demonstrate safe and well-tolerated BCP doses as high as 100 mg, a 10x increase compared to the natural daily human exposure
  • This is the first published study to demonstrate that BCP has poor bioavailability in humans
  • This is the first published study to reveal there is no significant difference between men and women for both investigated formulations and all investigated PK endpoints

The new clinical trial was conducted by Geocann®, a global cannabis organization that combines clinically researched cannabinoids and terpenes with technologically advanced drug delivery system technologies that increase absorption and bioavailability for maximum health benefits.

Reference more on the new human clinical trial here: https://www.mdpi.com/1420-3049/27/9/2860

Widely regarded as today’s best-in-class CBD product produced under the highest ethical and quality standards, TruZen® has also been validated as a superior CBD product in a previously published Clinical Trial Study: “A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects.”

Unlike typical CBD products, TruZen® CBD delivers a lipid-based, natural, hemp oil product to be delivered in a water-soluble form with no loss in bio-efficacy or absorption. Its patented VESIsorb® delivery system has been proven in previously conducted human clinical trials to increase absorption by mor than 400 times other CBD products. TruZen® CBD softgels disperse uniformly, transferring the CBD bioactives directly to the intestinal lymphatic system for boosted bioavailability and faster results. Benefits start in 90 seconds, and users will feel the full effect within 30 to 60 minutes. TruZen® CBD is 4.4 times more bioavailable than the leading CBD brand made with MCT oil. Tests show that the human body needs only 25 mg of TruZen® CBD to their 100 mg.

According to TruZen® Health VP Operations and Co-Founder, Michael Lioon, “we are very excited by the results of this first ever human-based clinical trial, validating our proprietary TruZen® formula with VESIsorb®’s superior potency and absorbency of β-caryophyllene (BCP). Our commitment to providing the highest quality, clinically proven products is stronger than ever today.”

TruZen® CBD is manufactured by TruZen® Health, continuing its legacy of three family generations and 70 years of nutraceutical experience, with products produced under the highest ethical standards. TruZen® CBD is the first product it has ever offered directly to consumers.

TruZen® Health is offering all new customers an introductory 10-Day trial of TruZen® CBD. To learn more, please visit https://www.truzenhealth.com/10-day-trial-special/.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. **EpiCor® is a registered trademark of Embria Health Sciences,

###

Share article on social media or email:

Soul Surgery Adds An Eating Disorder Residential Treatment Facility To Its Addiction And Mental Health Recovery Center


“I am thrilled to be a part of an organization that understands how critical the need for high-quality, customized eating disorder treatment programs are in the U.S. right now,” said Simmons.

Soul Surgery, a Scottsdale, Ariz.-based leading integrative medicine addiction center for those suffering from drug and alcohol addiction and mental health challenges, announced today it will begin accepting adults for its new eating disorder residential treatment facility, “RevealED” in January 2023.

RevealED was created out of community needs and unfortunate trends, illustrating that eating disorders are on the rise globally, increasing from 3.4% to 7.8% in 2022. Approximately 28 million Americans will have an eating disorder in their lifetime. Eating disorders are among the deadliest mental illnesses, second only to opioid overdose. More than 10,000 deaths yearly result from an eating disorder – about one every 52 minutes.

RevealED is accepting clients to begin treatment in the new year, offering a holistic, individualized program specific to each client’s needs, including trauma, mental health, nutrition counseling, re-feeding with chef-prepared meals, chiropractic services, biofeedback, EMDR, acupuncture, massage, nutrition, vitamin and nutrition IV therapy and more. All services are provided on-site at RevealED, a luxury, private facility in North Scottsdale. This is unique as most treatment facilities will refer patients to multiple providers for ancillary services, significantly decreasing the possibility that a client will complete all necessary components of a body, mind and spirit holistic, integrative medicine approach.

Treatment plans will vary and typically can last 30 days to six months. RevealED will also specialize in treating athletes. Athletes will follow a treatment track and work closely alongside a holistic wellness coach and Registered Dietitian and have the opportunity to integrate movement in their life with moderation by utilizing Soul Surgery’s full-service fitness center.

“We’ve had clients here at Soul Surgery who come in for another primary condition like drug or alcohol abuse, and they also have an eating disorder,” said Soul Surgery CEO & Founder John Mulligan. “Historically, we didn’t have the programming or the team to manage that until Melodie Simmons joined our team as Corporate Clinical Director. Her background, expertise, and passion is in eating disorders, and she has helped us hire the right experts to develop an offering that rivals anything else in the industry.”

Simmons is an accomplished leader licensed in Arizona as a professional counselor, a registered supervisor on the Arizona Board of Behavioral Health Examiners, a Certified Eating Disorder Specialist – Supervisor, and an American College of Healthcare Executives member. She will earn her Doctorate in Healthcare Administration in May 2023. Additionally, she is the 2023-2025 President of the International Association of Eating Disorder Professionals (iaedp) Phoenix Chapter and is the 2021-2022 iaedp Marketing Committee Chair.

“I am thrilled to be a part of an organization that understands how critical the need for high-quality, customized eating disorder treatment programs are in the U.S. right now,” said Simmons. “There are wait lists at most eating disorder treatment facilities today. We will help people gain the manageability of their lives and help them find their identity apart from food, weight, size or shape, and find meaning, purpose, and value to be one’s authentic self.”

Soul Surgery’s unique blend of cutting-edge, evidence-based treatment, upscale facilities, and passionate and professional staff give clients the best chance of removing their physical and mental obsession to become recovered. Treatments are offered at Soul Surgery’s state-of-the-art rehabilitation centers and behavioral health facilities in North Scottsdale. Each location provides luxurious accommodations in a setting removed from the stresses of daily life. The necessary structure for recovery is balanced with unique opportunities for reflection and growth in an ideal environment.

Soul Surgery accepts most major health insurance plans.

For more information, please visit http://www.soulsurgery.com or call 480-637-2474.

About Soul Surgery

Scottsdale-based Soul Surgery is a premier integrative medicine addiction center offering medical detox, outpatient, and residential treatment programs for alcohol and drug addiction recovery, eating disorder recovery, and mental health challenges. Soul Surgery is a leader in fentanyl addiction and stands out as Arizona’s leading dual-diagnosis treatment facility. http://www.soulsurgery.com

Share article on social media or email:

“Everyday Heroes 3” Named Hot New Release on Amazon in First Day


EVERYDAY HEROES 3

EVERYDAY HEROES 3

This is not only a big victory for the thoughtful team of co-writers but also for the volunteers at Habitat for Humanity who work tirelessly to build homes for those in need, and those being awarded digital bonuses.

Best-selling author and Direct Marketing expert, Matt Bacak with his 31 co-authors set out to break records with the release of “Everyday Heroes 3: A Collection of Inspirational and Motivational Stories from Around the World” and in less than a full day, they have certainly done that.

The book was released online at 9am EST, Friday November 17 and has already earned multiple accolades on Amazon and their book site. Amazon rankings include:


  • #1 Philosopher Biographies
  • #1 Business Professional’s Biographies
  • #1 New Releases, Philosopher Biographies
  • #1 New Releases, Business Professional’s Biographies
  • #2 New Releases, Professional and Academic Biographies
  • #3 New Releases, Biography and History
  • #10 New Releases, Business and Money

Additionally, the co-authors are offering almost $2,000 in digital bonuses and donating all book sale royalties to Habitat for Humanity, a non-profit organization that helps communities around the world build or improve homes for families in need. “Everyday Heroes 3” contributors believe Habitat for Humanity emulates the mission of the series. This “blitz buying” approach has worked well for these authors in the past and they are thrilled at the results to-date.

“The response to ‘Everyday Heroes 3’ is so exciting,” says Bacak. “This is not only a big victory for the thoughtful team of co-writers but also for the volunteers at Habitat for Humanity who work tirelessly to build homes for those in need, and those being awarded digital bonuses.”

“Everyday Heroes 3” is a special tribute to all of the hard-working, inspiring people that offer their time to the benefit of others. It is empowering with a beautiful dash of humility that encourages readers to take even the smallest step toward becoming an everyday hero themselves.

“Continuing to raise awareness to causes close to our hearts will always be the soul of our shared mission,” continues Bacak, “Everyone is so grateful to see all of those who have purchased a copy and those who plan to soon.”

The co-authors of “Everyday Heroes 3” include entrepreneurs, business owners and leaders from all over the world, including:

Matt Bacak, Adam Baetu, Devon Brown, Dr. Ivan Carney, Dr. Chase Dansie, Ron Douglas, Richard Fedrizzi, Reed Floren, Tracy Grote, Mark Hartmann, Nat Hecht, Dr. Kate Hughes, Jeremy Kennedy, Jeanne Kolenda, Aaron Landreth, Alicia Lyttle, Ricky Mataka, Zach Maxwell, Anthony McCarthy, Barry C. McLawhorn, Mike Molloy, Anthony Thomas Parker, Michael Penland, Michael Powell, Ani Railkar, Preston Rahn, Marlon Sanders, Koni Scavella, Paula Slavens, Mr. X, Rob Wallace, Harvey Zemmel.

For more information on “Everyday Heroes 3: A Collection of Inspirational and Motivational Stories from Around the World” visit http://EverydayHeroesBook.com and share your review on Amazon.

Share article on social media or email:

ProMach Bolsters Retort Portfolio with Acquisition of Ferlo


Ferlo logo

Ferlo manufactures a large range of autoclaves used around the world

The people and products at Ferlo give ProMach a broad line of retort solutions and improve our support capabilities. We are excited about the growth opportunities at Ferlo. — Mark Anderson, ProMach President and CEO

ProMach, a worldwide leader in processing and packaging solutions, announced today the acquisition of Ferlo, a leading manufacturer of retorts, pasteurizing tunnels, and associated product handling automation systems commonly used to provide shelf-stable food products with expanded shelf life. The acquisition of Ferlo increases ProMach’s existing position in processing equipment, expanding its international presence in the retort segment as well as strengthening its manufacturing capacity and supply chain partnerships.

For over 50 years, Ferlo has tailored sterilization systems to the specific needs of customers in the food and pharmaceutical industries. Ferlo’s core offerings include a variety of autoclaves and pasteurizing tunnels for cooking and sterilizing foods, beverages, and pharmaceutical products, complemented by a range of delivery systems to accommodate the material handling of a variety of package types and production processes.

ProMach’s existing portfolio includes product brands Allpax and Stock America, with complementary retort room offerings predominately serving the North American market. Ferlo, based in San Adrián, Navarra, Spain, largely serves the global market outside of North America with systems installed across Europe, South America, South Africa, the Middle East, India, and Asia.

“Ferlo’s significant presence and strong customer relationships outside North America make it a great fit with our existing business,” said Mark Anderson, ProMach President and CEO. “They’ve built tremendous brand reputation serving many large global companies, and it’s exactly what we need as we continue to expand internationally.”

ProMach’s Allpax product brand has been working with Ferlo for nearly two decades, utilizing its manufacturing competency to assist in supplying retort room equipment. “It’s something they excel at,” said Greg Jacob, Senior Vice President of ProMach’s Handling and Sterilizing business line. “While they do an outstanding job outfitting Ferlo branded retort systems, they also have a best-in-class process to efficiently manufacture high-quality pressure vessels, which has developed into a great manufacturing partnership between the businesses.

Ferlo and its entire staff are joining the ProMach team as part of ProMach’s Handling & Sterilizing business line under the leadership of Greg Jacob. Current Ferlo owner and President, Rafael Lopez, will join ProMach as Vice President and General Manager of Ferlo. ProMach will continue to invest in Ferlo’s team, brand, products, services, facility, distribution relationships, and research and development efforts to further advance its position as a leader in processing technologies.

“Working with ProMach’s product brands firsthand over the years, I’ve witnessed their ability to execute time and time again and win large projects,” said Mr. Lopez. “The number of orders we’ve fulfilled for Allpax and Stock America speak for themselves. I’m looking forward to taking our strategic relationship to the next level, as I feel we are well-positioned to increase our global capacity and service customers around the globe.”

ProMach continues to grow its international footprint to better provide localized support for customers across its product segments. “Having a reliable international network is vital for our global customers,” Mr. Anderson explained. “And we want to deliver great customer service all over the world to them. The people and products at Ferlo give ProMach a broad line of retort solutions and improve our support capabilities. We are excited about the growth opportunities at Ferlo.”

For more information about Ferlo please call them at +34 948 670322 or visit them online at http://www.Ferlo.com.

About ProMach

ProMach is a family of best-in-class processing and packaging solution brands serving manufacturers of all sizes and geographies in the food, beverage, pharmaceutical, personal care, and household and industrial goods industries. ProMach brands operate across the entire packaging spectrum: filling, bottling and capping, decorative labeling, flexibles and trays, pharma, handling and sterilizing, labeling and coding, and robotics and end of line. ProMach also provides systems and integration including turnkey solutions, design/build, engineering services, and productivity software to optimize packaging line design and deliver maximum uptime.

ProMach designs, manufactures, integrates, and supports the most sophisticated and advanced packaging solutions in the global marketplace. Its diverse customer base, from Fortune 500 companies to smaller, privately-held businesses worldwide, depends on reliable, flexible, technologically advanced equipment and integrated solutions. ProMach is headquartered near Cincinnati, Ohio, with manufacturing facilities and offices throughout North America, Europe, South America, and Asia. For more information about ProMach, visit http://www.ProMachBuilt.com.

Share article on social media or email:

Nationally Renowned Plastic Surgery Group is the First in California to Offer patients “See Yourself in Sientra,” a Smart Mirror Allowing You to “Try-On” Breast Implants


News Image

“Being able to “try-on” different options of results before my surgery made the decision so much easier for me to make. It took so much of the pre-surgery stress away knowing that I had a clear idea of what I would look in different implant sizes and profiles!” – Jackie S.

At CosmetiCare in Newport Beach, the doctors and staff are continuously searching for leading industry technology that will allow their patients to find the most confidence in their decision-making when considering plastic surgery. Proud to be the first and only practice in California to offer “See Yourself in Sientra,” CosmetiCare is offering its patients a first-hand preview of what intended sizing could look like on their own body with live movement, multiple sizes and near-instant results.

“See Yourself in Sientra,” a smart mirror designed by Sientra and Crisalix, provides plastic surgeons with another tool to supply patients with realistic expectations during the consultation process. This first-of-a-kind “magic mirror” is utilized on patients unsure which breast implant size, profile, type, and style will be best for them and their bodies. The patient will stand in front of the mirror and will be able to experience seeing what their body could look like with a breast augmentation, and will also be able to see multiple views and angles.

“This is a fabulous and state-of-the-art technology.” says founder and Medical Director Dr. Niccole. “These patients can see their full body standing in front of this mirror. You can go up and down in sizing, change implant profile and type, and provide as many options as possible until the patient is happy with their look. It completely changes how we used to do surgical consultations; this provides much more information to the patient.”

Before this mirror was introduced, doctors could only walk patients through their potential results and showcase results on prior patients. There were also prior visualization options on the market, but without the revolutionary technology provided by the partnership between Sientra and Crysalix patients still weren’t able to see the results on themselves in real time. “See Yourself in Sientra” lets patients walk in front of a mirror and try on their results in real time to make the choice that best fits their bodies and aesthetic goals.

“Being able to “try-on” different options of results before my surgery made the decision so much easier for me to make. I was able to see what my body looked like in a variety of sizes and profiles, and could picture how I would look in different tops and dresses. It took so much of the pre-surgery stress away knowing that I had a clear idea of what I would look like!” – Jackie S., actual patient of CosmetiCare

If you’ve been considering a breast augmentation procedure and would love to try out this smart mirror, schedule your complimentary try-on appointment with one of our Patient Consultants today by calling 949-558-2573. If you are curious to know more about CosmetiCare and the surgical and non-surgical aesthetic treatments offered, follow us on Instagram or Facebook to see behind-the-scenes treatment content, education pieces, and transformative results.

ABOUT COSMETICARE

With a passion for providing the best patient care available, Dr. Michael Niccole founded CosmetiCare in 1982 and has built it into one of the leading plastic surgery and MedSpa centers recognized throughout the nation. CosmetiCare’s meticulously cultivated, award-winning team of doctors and medical professionals has provided more than 100,000 stories of transformation for over 35 years. To learn more about CosmetiCare, visit http://www.cosmeticare.com

Share article on social media or email:



$5.1 Billion Histology and Cytology In Vitro Diagnostics (IVD) Market, reports Kalorama Information


2021 was a fast growth year for the histology and cytology IVD market.

The market for the testing of tissues and cells, histology and cytology in vitro diagnostics reached $4.9 billion in 2021 per market research firm Kalorama Information and is expected to grow to $5.1 billion in 2022. Last year, 2021 was a fast growth year for the market. The global histology IVD market grew 23.5% from 2020 to 2021 reflecting strong rebounding after the market experienced negative effects from the COVID-19 pandemic during 2020. The market stabilized from COVID and now Kalorama Information analysts expect a 4.2% CAGR.

Kalorama Information made the finding in its report Histology and Cytology IVD Market Update.

Histology and cytology are the study of tissue (and cells, respectively). Histological or tissue analysis involves a two-step procedure: preanalytical sample preparation and advanced staining. Sputum, cervical and synovial fluids, and bits of tissue that have been biopsied or surgically removed are processed, placed on glass slides, and stained to characterize targeted cellular constructions, tissue morphology and cell components. Trained technologists perform a first pass screen of the stained slides. Pathologists further investigate tumor section slides and others that are found to have suspicious or aberrant cells. The tests are used primarily to detect cancer and infectious agents in tissue and cervical fluid, but the reader is reminded that every organ or piece of tissue removed from a patient during surgery is also processed and analyzed in this two-step procedure.

Physicians diagnose the majority of cancer cases through identification of a tumor’s source, be it cancer of the liver, lungs, or kidney and so on. However, in many cases, the pathologist may confirm a patient’s cancer diagnosis while being unable yet to find a source. They will then use a battery of test techniques including in situ hybridization (ISH), immunohistochemistry (IHC), immunofluorescence (IF), and molecular analysis of tumor cells, a toolkit of strategies to improve diagnosis in difficult cases.

Histology reagents and instruments can be segmented in the main categories shown below. All of these techniques involve analyzing cells either in surgical and biopsied tissue (histology) or body fluids (cytology). This includes traditional tissue stains, Pap tests, immunohistochemical stains, in situ hybridization staining (ISH), HPV tests.

Immunohistochemical (IHC) stains, initially the primary technique in histological diagnosis and analysis, use fluorescent and colorimetric labeled antibodies to detect enzymes, proteins and other analytes in tissue; over time, new, improved methodologies were developed, such as in situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques, which use DNA probes to detect pathogens and molecular structures in cells. These techniques provide pathologists and clinicians with gene and protein patterns to aid in distinguishing cell attributes that demonstrate their virulence for disease progression and sensitivity to specific therapeutics.

Traditional stains used on all types of formalin fixed, paraffin embedded tissues and fluids make up the most mature area in this market. The most widely used stain is the hematoxylin & eosin (H&E) stain used to provide a general overview of tissue structures and cells. Hematoxylin, a basic dye, stains nuclei blue due to an affinity to nucleic acids in the cell nucleus; eosin, an acidic dye, stains the cytoplasm pink. There are hundreds of various other techniques that have been used to selectively stain cells and cellular components. The most widely used special stains include Congo red, elastin, Feulgen, giemsa, Gomori, iron, Masson, PAS (periodic acid schiff) and reticulin.

Vendors in the space include:

  • BioMeda
  • Biosource
  • Dako/Agilent
  • Immunon
  • Ortho Clinical Diagnostics
  • Roche/Ventana
  • Siemens Healthcare
  • Sigma Aldrich
  • Spectrum

About Kalorama Information:

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

Earth’s Edge Wellness Hosting Upcoming “Brazen In-Bodyment Retreat” Virtually in January


News Image

“75% of our participants leave symptom free by the time they have completed the brazen inbodyment retreat. By the end of this retreat, attendees will be in touch with their body and mind and know which steps to take in the future” says Yoni Banayan.

Many people struggle with body and food concerns, and Earth’s Edge Wellness created a retreat for those who want to experience significant results in a short amount of time. They address the body before the mind, which is exactly contrary to what treatment centers do around the globe. While not necessarily the cause, they treat eating disorders as primarily dissociative disorders, as the Earth’s Edge Wellness team believes that is the quickest and most effective way of resolving the disorder. Earth’s Edge Wellness’ practitioners rely on spiritual healing and bridging the gap between holistic and scientifically informed treatment. This experienced team of leading holistic and traditional practitioners provides clients with the tools they need to overcome food and body struggles. The retreat is led by founder, Yoni Banayan, a nationally licensed marriage and family therapist who provides training and sessions for schools, treatment facilities, groups and individuals. He is accompanied by Guru Cosmin Mahadev Singh, a respected Kundalini yoga instructor and an accomplished traditional reiki master, Chelsea Clark, a registered dietitian nutritionist and a certified personal trainer and Kristan Lee Reada workshop leader and teacher of the modalities of Shamanic Womancraft.

Working together, the Earth’s Edge Wellness 3-day Brazen In-Bodyment retreat helps to address the blockages getting in the way of following through on taking care of the body and mind, such as the disconnection from soul/consciousness, disconnect from the body’s natural cues, lack of education about nutrition and mental hygiene and lastly a misaligned relationship with the mind and body.

The retreat schedule is as follows:

Day 1: The Real Secret Ingredient: Your Soul!

Day 2: Your underlying motives for your behaviors and grounding techniques to help you move forward

Day 3: Food Rules and Food Psychology 101

BONUS: Get that Body Connection: Education and techniques on how to connect to your body (so you have the skills to know what your body needs going forward), expert and group IG support group, Earth’s Edge Wellness merch, nutrition workbooks on hunger fullness, sports nutrition and meal planning and a 30 minute 1:1 ​integration coaching call.

Link to retreat information: https://www.earthsedgewellness.com/virtual-eating-disorder-retreats/

“75% of our participants leave symptom free by the time they have completed the brazen inbodyment retreat. By the end of this retreat, attendees will be in touch with their body and mind and know which steps to take in the future” says Yoni Banayan.

More About Earth’s Edge Wellness:

Earth’s Edge Wellness’ approach is very simple. They talk to clients and see what help is needed. They then gather their team of people with the skill sets and personalities that will help clients get to a place where food, body or exercise are sources of joy instead of pain. They also directly address concerns that clients have by using techniques that involve the body as well as the unconscious mind. Earth’s Edge Clients choose their own treatment modalities and ideal treatment team based on a schedule that works for them. With Earth’s Edge Wellness, those with eating disorders and disordered eating can create a long term approach to get back to living life in record times. For more information, please call 702-582-9474 or visit http://www.earthsedgewellness.com.

Share article on social media or email:

Biopharma Excellence’s push for African vaccine equity is among 200+ successful vaccine-related projects to date


This is a highly dynamic field at the forefront of science

PharmaLex Group’s Biopharma Excellence service line, launched last year, has seen large-scale take-up of its vaccine expertise across more than 200 projects already delivered internationally. These have included creating an optimum environment to enable localised vaccine manufacturing in Africa, with a view to enabling greater equity in vaccine access across the continent. In June, linked to this, Biopharma Excellence was invited to witness the signing of a new Memorandum of Understanding (MoU) between Rwanda FDA and Ghana FDA, around the provision of reciprocal technical assistance related to medicines and vaccines manufacture regulatory oversight.

Since inception, the deeply experienced Biopharma Excellence team has successfully worked on a vast array of vaccine-related projects, working closely with clients including large and mid-sized pharma organizations and biotech startups, state institutions, non-profit organisations and academia, to streamline the path to market for these critical products.

The Biopharma Excellence team comprises specialist virologists, vaccinologists, molecular biologists, and leading ex-regulators with a rich understanding of the aetiology of infectious agents, as well as public health/health policy needs and expectations.

This impressive pool of in-house knowledge has enabled Biopharma Excellence to hone a precise vision of how the CMC, non-clinical and clinical development of novel vaccine technologies can be optimally blended with smart regulatory solutions worldwide. “We’re in a very comfortable position to share our knowledge and to support interested developers to rapidly provide their solutions to the market,” commented Dr. Michael Pfleiderer, lead scientist at Biopharma Excellence.

Against the backdrop of the still present SARS-CoV-2 (COVID-19) pandemic, demand for Biopharma Excellence’s vaccine insights has been acute. The first vaccines were licensed with unprecedented speed – in a matter of months rather than years – supported by adapted, fit-for-purpose regulatory approaches. “Given this rapidly-evolving situation, fast, flexible, and innovative solutions have been – and continue to be – paramount,” Dr Pfleiderer noted.

Since the onset of the pandemic, Biopharma Excellence has been deeply involved in all aspects of regulatory oversight of pandemic vaccines, and has developed comprehensive regional and global regulatory strategies for more than 20 SARS-CoV-2 vaccines, including novel platform technologies such as mRNA vaccines.

It has also supported pharma/biotech clients at all stages of development- from securing funding, partnering, CMC, non-clinical, clinical development all the way to successful fast-track approvals.

Its work to help establish vaccine manufacture and establish vaccine equity in Africa stems from an engagement with a major global brand, exploring how to localise vaccine manufacturing in Africa. The concept developed by Biopharma Excellence, which it dubbed Reg and Tech Transfer, has been accepted by pan-African organisations, and led to a contract to explore opportunities to enhance regulatory systems in the region. This is just one of a number of initiatives the team has been working on across the continent.

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence, under the PharmaLex brand. The global team of 70+ scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services geared to developers of biopharmaceuticals such as cell & gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars. It is headed up by Dr. Christian K. Schneider, formerly Chief Scientific Officer at the UK’s MHRA, who is also its Chief Medical Officer.

Biopharma Excellence, which has already brought big business to Pharmalex, has shared its expertise and insights widely via published thought leadership on relevant issues ranging from Accelerated development and licensure of Coronavirus vaccines to Vaccine Development in Paediatric Populations – How to Proceed for SARS-CoV-2 Vaccines?.

Its expertise around vaccines has seen particularly pronounced demand, because of the field’s unique characteristics. “This is a highly dynamic field at the forefront of science,” Dr. Pfleiderer said. “It is subject to new technology, scientific progress, and new epidemics around the world, and it’s inevitable that there will be a lag in the regulators’ ability to adapt. That’s why there’s a need for experts like us who can adapt to these rapidly-changing situations. We understand that the procurement of vaccines is very different to any other product. They could be given to entire populations in a country or geographic region, so safety and clear communication about the science is paramount. Vaccines are paid for by governments too, which means that the entire infrastructure around it is different to other pharma categories.”

-Ends-

About Biopharma Excellence

Biopharma Excellence by PharmaLex partners with biopharmaceutical companies on their journeys toward the development and delivery of scientific advances and product breakthroughs. Its worldwide team of experts comprises multidisciplinary scientists; specialists in cell and gene therapies, vaccines, monoclonal antibodies and process development; clinicians; and former regulators. Biopharma Excellence has a proven track record in developing solutions to the scientific, regulatory and commercialization challenges that are unique to biopharmaceutical companies. These global solutions are grounded in major regulatory markets across Europe, the United States and Australia. More at http://www.biopharma-excellence.com.

For further information, please contact:

Carina Birt, PR for Biopharma Excellence

carina@sarumpr.com

+44 7970 006624

Share article on social media or email:

Prevent Blindness Declares Second Annual Geographic Atrophy Awareness Week as Dec. 5-11, 2022


Prevent Blindness declares Dec. 5-11, 2022, as the second annual Geographic Atrophy Awareness Week, providing free educational resources to the public.

“New research and treatment options are promising for geographic atrophy,” said Jeff Todd, president and CEO of Prevent Blindness. “We encourage patients to work closely with their eye doctors to lessen the damaging effects of GA and preserve their vision for the future.”

Prevent Blindness, the nation’s leading nonprofit eye health organization, is announcing the second annual Geographic Atrophy (GA) Awareness Week as Dec. 5-11, 2022. GA is an advanced form of dry age-related macular degeneration (AMD) which affects central vision. GA can lead to progressive and permanent vision loss.

According to a new study “The Prevalence of Age-Related Macular Degeneration in the United States In 2019” published in JAMA Ophthalmology, an estimated 19.83 million Americans were living with AMD in 2019. Of those, 18.34 million Americans had early AMD and 1.49 million had late-stage vision-threatening forms of AMD (“late-stage AMD” included choroidal neovascularization and geographic atrophy).

To help educate the public on GA, Prevent Blindness has created a variety of resources in English and Spanish, including a downloadable fact sheet and a series of shareable social media graphics. Prevent Blindness also provides a dedicated webpage. Prevent Blindness developed the content of these resources with funding provided by Apellis Pharmaceuticals, Inc.

A new episode of the Prevent Blindness Focus on Eye Health Expert Series, “Geographic Atrophy and Patient Support,” is now available, featuring Prevent Blindness, Ohio Affiliate Past President and CEO, Sherry Williams, who offers her unique perspective of working to advance vision and eye health services as a professional, as well as sharing her personal story of helping to provide ongoing support to her mother, who has GA.

Prevent Blindness offers an additional episode on GA from the Focus on Eye Health Expert Series, where Jeff Todd, president, and CEO of Prevent Blindness, interviews Dr. Janet S. Sunness, medical director of the Richard E. Hoover Low Vision Rehabilitation Services at the Greater Baltimore Medical Center. Dr. Sunness directed a National Institutes of Health-funded natural history study of geographic atrophy. Her research has focused on using visual function measures to better understand retinal disease, particularly AMD and Stargardt disease.

Patients with GA in one eye are more likely to develop it in the other eye. Additional risk factors for developing GA include:


  •     Family history of AMD
  •     Age – over 60 years old
  •     Race – Caucasians have a higher rate of AMD
  •     Light-colored eyes
  •     Smoking
  •     Genetics
  •     Heart disease
  •     Diabetes
  •     Women not using menopausal hormone replacement therapy
  •     High blood pressure (hypertension)
  •     High cholesterol
  •     Obesity
  •     High sun exposure throughout the lifespan
  •     Poor diet with a low intake of fruits and vegetables (specifically dark green leafy vegetables)

For GA patients and their care partners, Prevent Blindness recently launched its updated online resource Living Well with Low Vision. This free program provides a variety of free directories, a library of self-help guides, downloadable apps including the GuideME for AMD, access to clinical trial research, and recent news highlighting AMD research and lifestyle articles.

“New research and treatment options are promising for geographic atrophy,” said Mr. Todd. “We encourage patients to work closely with their eye doctors to lessen the damaging effects of GA and preserve their vision for the future.”

For more information on geographic atrophy, please visit https://preventblindness.org/geographic-atrophy. For a listing of vision care financial assistance programs in English or Spanish, visit https://www.preventblindness.org/vision-care-financial-assistance-information.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs, and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn, and YouTube.

###

Share article on social media or email:

Verinovum appoints new Chief Information Officer to lead strategy, technology investments


News Image

Steven Peterson

“Steven has more than 25 years of experience in organizing and leading teams to produce highly scalable SaaS solutions in the healthcare, financial, and media spaces.” — Mark McCurry, President and CEO of Verinovum.

Verinovum, a leader in health data curation and enrichment technology, has named Steven Peterson as Chief Information Officer.

Peterson, who specializes in business technology transformation, will help lead the company’s roadmap, strategy, and technology investments to support its goal to deliver clean, actionable data to payers and providers. As CIO, he will guide the people, processes, and technologies within Verinovum to ensure delivery of the full potential of measurement, clinical improvement, and innovation opportunities for clients.

“We are excited to have such a distinguished technology and information leader join our team. Steven has more than 25 years of experience in organizing and leading teams to produce highly scalable SaaS solutions in the healthcare, financial, and media spaces,” said Mark McCurry, President and CEO of Verinovum. “His passion for integrity, equity, and strategic development will truly augment Verinovum’s mission to empower and enable payers and providers to deliver better patient outcomes and avoid unnecessary cost.”

Before joining Verinovum, Peterson was Chief Technology Officer at Proficient, Inc., in Greensboro, North Carolina, where he managed all aspects of product development, quality, operations, system architecture, and related business processes. While there, he restructured the technical team to enable a new product direction using modern software deployment strategies. Peterson has also served as Vice President of Enterprise Architecture Primary at MedFusion, Inc., leading the architectural oversight of the company’s development efforts. In addition, as Director of ProviderLink Technology at Covisint, he managed the company’s ProviderLink solution, which provides a SaaS healthcare communication management program to connect more than 14,000 users at over 450 healthcare organizations.

Peterson holds a Bachelor of Science degree in computer science from North Carolina State University.

About Verinovum

Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, and partner organizations to improve operating performance and quality with actionable data. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the right information, in the right format, at the right time, so it may be tailored and curated to fulfill specific use cases and achieve mission-critical clinical and business goals. Discover more at Verinovum.com.

Share article on social media or email: